All sponsors

The United Bio-Technology (Hengqin) Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-35
RECRUITING4
READOUTS ≤12 MONTHS3
Open The United Bio-Technology (Hengqin) Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
MASH
NCT07145151
P2RecruitingMetabolic Dysfunction-associated Steatohepatitis (MASH)1562027-06-04
UNIGUIDE-1
NCT07659574
P3RecruitingType 2 Diabetes3602027-09-24
UBT251 Injection 4.0 mg
NCT07648225
P3Active, not recruitingObesity & Overweight6002027-09-29
UNIGUIDE-2
NCT07653477
P3RecruitingType 2 Diabetes9562028-02-29
UNISHAPE-OSA-1
NCT07767942
P3Not yet recruitingObstructive Sleep Apnea, Obesity1502028-09
UNISHAPE-OSA-2
NCT07806851
P3Not yet recruitingObstructive Sleep Apnea; Obesity1502029-03
UBT251
NCT07134335
P2RecruitingObesity &Amp; Overweight; Chronic Kidney Disease1802030-07-11